Acerus Pharmaceuticals Corporation (ASP)

0.040
+0.010(+33.33%)
  • Volume:
    294,999
  • Bid/Ask:
    0.030/0.040
  • Day's Range:
    0.030 - 0.045
  • Type:Equity
  • Market:Canada
  • ISIN:CA00444G1081
  • CUSIP:00444G108

ASP Overview

Prev. Close
0.03
Day's Range
0.03-0.045
Revenue
2.08M
Open
0.045
52 wk Range
0.025-0.065
EPS
-0.03
Volume
294,999
Market Cap
61.5M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
133,733
P/E Ratio
-
Beta
0.68
1-Year Change
-11.11%
Shares Outstanding
1,537,588,081
Next Earnings Date
Mar. 08, 2022
What is your sentiment on Acerus Pharmaceuticals Corporation?
or
Market is currently closed. Voting is open during market hours.

Acerus Pharmaceuticals Corporation Company Profile

Employees
10
Market
Canada

Acerus Pharmaceuticals Corporation is a Canada-based specialty pharmaceutical company. The Company is focused on the commercialization and development of prescription products with a primary focus in the field of men's health. Its product, Natesto, is a testosterone nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism. It has two product pipelines, such as avanafil, which is a chemical entity PDE5 inhibitor for the treatment of erectile dysfunction and Lidbree, is a short acting lidocaine formulation delivered through a device into the vaginal mucosal tissue. It also has product rights to Tefina, a clinical stage product aimed at addressing an unmet need for women with female sexual dysfunction. Its non-prescription product includes Elegant, which is a vaginal moisturizer. Its primary market is the United States where it commercializes its product with their contract commercial provider Syneos Health (Syneos).

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong SellStrong BuySell
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong SellStrong BuyStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.